SCOR's Quiet Victory Lap: The Arbitration Fog Lifts Just as the Market Softens
The key message today is simple: SCOR continues to deliver on its Forward 2026 strategic plan and is approaching its next strategic chapter from a position of confidence and strength.
SCOR's Q3 2026 call opened with the CFO's victory lap: net income of EUR 615 million for the first nine months, a 19.3% annualized ROE, a 221% solvency ratio and a P&C combined ratio of 81.3%. Those are exceptional numbers for a reinsurer that spent the last few years rebuilding credibility. The strategic plan now has a date: 3 December in London, when CEO Thierry Leger will present the next cycle. His message was unmistakable: “SCOR is in a much stronger position today and can aim higher.” — Thierry Leger, Group CEO · 2026-10-30
But the interesting part of this call is not the headline. It is the gap between the confidence of the prepared remarks and the anxiety of the Q&A. Analysts spent most of the hour asking about the attritional loss ratio and the buffer build inside it. That is not a new debate. In July, Leger said “we think this strong attritional underlying should continue for a number of quarters to come.” — Thierry Leger, Group CEO · 2026-07-30 On this call, the answer to how much buffer remains was still “we wouldn't comment on a quarterly basis.” — Philipp Ruede, Group CFO · 2026-10-30 The opacity is deliberate, but it leaves the market unable to distinguish genuinely sticky underwriting margins from a favourable reserve cycle. That tension is the real story.
The arbitration fog lifts
The most conspicuous absence on this call was the Covéa arbitration. For several quarters it dominated the Q&A — solvency tail risk, liquidity, the second arbitration, the settlement agreement. In July, management was still reassuring investors: “on the second arbitration, we are very confident... The key one was the first one. That's now behind us.” — Jean-Paul Conoscente, Executive (likely underwriting or related function) · 2026-07-30 On Friday, the prepared remarks did not mention it at all. The only reference came from an analyst asking about Life cash flow post the Covéa arbitration, and the CFO's reply was that it is “only a small portion of the overall cash flow.” — Philipp Ruede, Group CFO · 2026-10-30 The Covea arbitration overhang has not disappeared from the legal record, but it has disappeared from the investment narrative. That is a genuine de-risking — and it shifts the focus to capital allocation.
Life & Health: from reset to hunt
The second shift is in Life & Health. Seven quarters after the 2024 reset, performance is in line with expectations, and Leger is nearly ready to declare victory. He wants eight quarters of evidence, but his language has changed from defence to offence: “I'm today very positive that we will conclude that we have done what was needed and can now clearly go and hunt for the opportunities.” — Thierry Leger, Group CEO · 2026-10-30 That is a meaningful pivot. In July, the message was still about a U-shaped recovery and patience while financial solutions and longevity deals took time to close. Now the CEO is talking about hunting. The new business CSM mix is improving toward financial solutions and longevity, and the Life insurance service result came in at EUR 119 million for the quarter with positive experience variance of EUR 12 million. The risk adjustment fell from EUR 2.5 billion at full-year 2025 to EUR 2 billion at nine months, mostly FX and rates; the CFO also deferred a precise P&C CSM amortization figure to a follow-up. Small blemishes, but not thesis-changing.
P&C: the softening is here, the discipline is the pitch
P&C remains the engine, but the cycle is turning. Leger was explicit: “We expect competition to remain high and have a clear priority for our underwriters: margin and quality over volume.” — Thierry Leger, Group CEO · 2026-10-30 Jean-Paul Conoscente added that January treaty renewals are late and, in European cat, “we see price decreases, I'd say, high single digit, low double digit is what we're seeing so far.” — Jean-Paul Conoscente, Comex member / Executive · 2026-10-30 That is the softening the market has been waiting for, and it follows the U.S. property cat price declines SCOR flagged earlier in the year. SCOR's answer is to lean on its Tier 1 franchise — the same phrase Michael Huttner asked it to explain a year ago, when Leger said it means clients have “a genuine and general desire to see us with a higher share on their programs than we have today.” — Thierry Leger, Group CEO · 2025-10-31 The pitch is that SCOR can be selective, grow specialty and alternative solutions, and use retrocession actively rather than chase volume.
The wildcard is EGPI revisions. They were the top-ranked company keyword this quarter, even though management said the impact was smaller. Conoscente was careful: “We anticipate sort of the EGPI revisions continue to be an issue for clients going forward. So we're adding some conservatism in our own EGPI estimates.” — Jean-Paul Conoscente, Comex member / Executive · 2026-10-30 That is prudent, but it also means reported P&C revenue growth — up 2.3% at constant FX — is still being buffeted by cedent estimates rather than pure underwriting momentum.
Why it matters
SCOR enters its next strategic cycle with the strongest balance sheet it has had in years, a fading legal overhang, and a Life portfolio that is no longer the problem child. That is why management feels able to aim higher. But the next phase will be judged on a different question: can SCOR compound capital when P&C pricing is falling? The company's answer is discipline over volume, which may mean lower revenue growth than peers. The market's answer will depend on whether the buffer builds are real and repeatable. For now, the call leaves both sides with their priors intact — bulls point to a 19.3% ROE and 221% solvency; sceptics point to an unquantified buffer and a softening cat market. The 3 December strategic plan is the next catalyst. Until then, SCOR is a quality reinsurer in transition, not yet a growth story.